Pergamon-Elsevier Science Ltd

SHERPA: Unknown

People

  1. Danishefsky
    Danishefsky
  2. Chiosis
    Chiosis
  3. Rosen
    Rosen
  4. Motzer
    Motzer
  5. Scheinberg
    Scheinberg
  6. Tan
    Tan
  7. Taldone
    Taldone
  8. Ouerfelli
    Ouerfelli
  9. Solit
    Solit
  10. Hudis
    Hudis

Groups

  1. Sloan Kettering Institute Faculty (143)
  2. Molecular Pharmacology and Chemistry Program Faculty (139)
  3. Department of Medicine (75)
  4. GSK Faculty (63)
  5. Solid Tumor Oncology Division (52)
  6. Center for Hematologic Malignancies (32)
  7. Sloan Kettering Institute Postdocs (30)
  8. Hematologic Malignancies Research (25)
  9. Breast Medicine Service (24)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (22)
Search Within
Formats
  1. Journal Article (218)
  2. Meeting Abstract (87)
  3. Book Section (7)
  4. Book Whole (2)
  5. Research Letter (2)
  6. Review (2)
  7. Conference Paper (1)
  8. Editorial (1)
Groups
  1. Sloan Kettering Institute Faculty (143)
  2. Molecular Pharmacology and Chemistry Program Faculty (139)
  3. Department of Medicine (75)
  4. GSK Faculty (63)
  5. Solid Tumor Oncology Division (52)
  6. Center for Hematologic Malignancies (32)

More Groups

People
  1. Samuel Danishefsky (73)
  2. Gavril Pasternak (19)
  3. Gabriela Chiosis (16)
  4. Ting-Chao Chou (16)
  5. Huajin Dong (10)
  6. Neal Rosen (10)

More People

Years
  1. 2024 (8)
  2. 2023 (3)
  3. 2022 (1)
  4. 2021 (1)
  5. 2020 (4)
  6. 2019 (4)

More Years

Publications
  1. EJC Supplements (82)
  2. Tetrahedron Letters (75)
  3. Bioorganic & Medicinal Chemistry Letters (27)
  4. Bioorganic & Medicinal Chemistry (24)
  5. Molecular Immunology (20)
  6. Neuropharmacology (15)

More Publications

Results (320)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study of XL281, a potent and selective inhibitor of RAF kinases, administered orally to patients (pts) with advanced solid tumors
    Meeting Abstract

    Schwartz, G. K.; Yazji, S.; Mendelson, D. S.; Dickson, M. A.; Johnston, S. H.; Wang, E. W.; Shannon, P.; Pace, L.; Gordon, M. S.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • Analysis of EGFR and KRAS mutations in circulating tumor DNA (cTDNA) from plasma of NSCLC patients in phase 2 trials of XL647
    Meeting Abstract

    Schimmolle, F.; Rizvi, N. A.; Vysotskaia, V. S.; Funke, R. P.; Dixon, S.; Buller, R. E.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • Phase I-II study of MDV3100 in castration resistant prostate cancer. The Prostate Cancer Clinical Trials consortium
    Meeting Abstract

    Scher, H.; Beer, T.; Higano, C.; Logothetis, C.; Shelkey, J.; Hung, D.; Hirmand, M.; Larson, S.; Fleisher, M.; Sawyers, C.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • RET inhibition: Therapeutic implications in thyroid cancer
    Meeting Abstract

    Mitsiades, N.; Fagin, J. A.; Pfister, D. G.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • A phase 2, single-arm study of volociximab (an anti-a5 beta 1 integrin antibody) monotherapy in patients with platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer
    Meeting Abstract

    Matthews, C. M.; Ho, S. N.; Barve, M.; Bell-Mcguinn, K. M.; Gilbert, L.; Penson, R. T.; Lengyel, E.; Weymer, S.; Gilder, K.; Schilder, R. J.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • A forward genetic screen in the mouse to identify novel genes that affect motor neuron development
    Meeting Abstract

    Liem, K. F.; Anderson, K. V.
    International Journal of Developmental Neuroscience (2008)

    Fulltext@MSK | Save
  • Regulation of ATF5 during cerebellar granule neuron progenitor proliferation and differentiation
    Meeting Abstract

    Lee, H. Y.; Angelastro, J. M.; Kenney, A. M.; Mason, C.; Greene, L.
    International Journal of Developmental Neuroscience (2008)

    Fulltext@MSK | Save
  • NPI-0052 (a 2nd generation proteasome inhibitor) Phase 1 study in patients with lymphoma and solid tumors
    Meeting Abstract

    Kurzrock, R.; Hamlin, P.; Gordon, M.; Hong, D.; Fu, S.; Younes, A.; Hannah, A.; Palladino, M. A.; Spear, M. A.; Aghajanian, C.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • The sodium-dependent phosphate transporter NaPi2b is a new target antigen in ovarian carcinoma and is recognized by the anticancer antibody MX35
    Meeting Abstract

    Kiyamova, R.; Gryshkova, V.; Filonenko, V.; Usenko, V.; Khozayenko, Y.; Gurtovyy, V.; Yin, B.; Ritter, G.; Gout, I.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • Stress, distress and support groups - Are they important?
    Meeting Abstract

    Kissane, D.; Grabsch, B.; Clarke, D. M.; Snyder, R. D.; Li, Y.
    EJC Supplements (2008)

    Fulltext@MSK | Save